ArticleTransboundary and emerging diseases2026
A Scoping Review of Machine Learning Applications Across Epidemiological Stages of Zoonotic Disease.
Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Scoping Review of Machine Learning Applications Across Epidemiological Stages of Zoonotic Disease.Transboundary and emerging diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging zoonotic diseases represent a significant threat to global health. While machine learning (ML) holds promise for their management, a comprehensive understanding of how these technologies are applied across the entire animal-to-human transmission pathway is lacking. This scoping review systematically maps ML applications in zoonotic disease management to identify research trends, methodological approaches, and critical gaps across different epidemiological stages and functional domains. We organize the literature along two dimensions: epidemiological stages, from animal hosts to human populations, and functional domain, including diagnosis, epidemiology, and intervention. We searched PubMed and Web of Science for studies on 14 preselected high-priority zoonotic diseases. The search string combined keywords for the selected diseases, ML techniques, and functional applications (diagnosis, epidemiology, and intervention). A total of 966 studies were included in the final analysis, of which 72.8% focused on COVID-19. Our analysis shows robust ML performance in clinical diagnostics, epidemic forecasting, and intervention optimization within human populations. However, critical gaps persist, only 1.96% of studies examined the animal-human interface, no ML models explicitly targeted spillover prevention, and studies on animal-reservoir surveillance remain limited. All spillover studies originated from high-income or upper-middle-income countries (UMICs), in contrast with low- and lower-middle-income countries (LMICs) contributing 21.4% of human-stage studies. These findings reveal a pronounced mismatch between research investment and spillover risk and highlight the need for greater emphasis on spillover mechanisms, enhanced integration of cross-species transmission dynamics, and methods suitable for surveillance in resource-limited settings. Addressing these imbalances is essential for advancing a shift from reactive outbreak response to proactive spillover prevention within a One Health framework.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.